Anti-PILRB/ FDFACT1/ FDFACT2 monoclonal antibody

Anti-PILRB/ FDFACT1/ FDFACT2 antibody for FACS & in-vivo assay

Target products collectionGo to PILRB/PILRB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1372-Ab-1/ GM-Tg-hg-MP1372-Ab-2Anti-Human PILRB monoclonal antibodyHuman
GM-Tg-rg-MP1372-Ab-1/ GM-Tg-rg-MP1372-Ab-2Anti-Rat PILRB monoclonal antibodyRat
GM-Tg-mg-MP1372-Ab-1/ GM-Tg-mg-MP1372-Ab-2Anti-Mouse PILRB monoclonal antibodyMouse
GM-Tg-cynog-MP1372-Ab-1/ GM-Tg-cynog-MP1372-Ab-2Anti-Cynomolgus/ Rhesus macaque PILRB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1372-Ab-1/ GM-Tg-felg-MP1372-Ab-2Anti-Feline PILRB monoclonal antibodyFeline
GM-Tg-cang-MP1372-Ab-1/ GM-Tg-cang-MP1372-Ab-2Anti-Canine PILRB monoclonal antibodyCanine
GM-Tg-bovg-MP1372-Ab-1/ GM-Tg-bovg-MP1372-Ab-2Anti-Bovine PILRB monoclonal antibodyBovine
GM-Tg-equg-MP1372-Ab-1/ GM-Tg-equg-MP1372-Ab-2Anti-Equine PILRB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1372-Ab-1/ GM-Tg-hg-MP1372-Ab-2; GM-Tg-rg-MP1372-Ab-1/ GM-Tg-rg-MP1372-Ab-2;
GM-Tg-mg-MP1372-Ab-1/ GM-Tg-mg-MP1372-Ab-2; GM-Tg-cynog-MP1372-Ab-1/ GM-Tg-cynog-MP1372-Ab-2;
GM-Tg-felg-MP1372-Ab-1/ GM-Tg-felg-MP1372-Ab-2; GM-Tg-cang-MP1372-Ab-1/ GM-Tg-cang-MP1372-Ab-2;
GM-Tg-bovg-MP1372-Ab-1/ GM-Tg-bovg-MP1372-Ab-2; GM-Tg-equg-MP1372-Ab-1/ GM-Tg-equg-MP1372-Ab-2
Products NameAnti-PILRB monoclonal antibody
Formatmab
Target NamePILRB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PILRB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PILRB/ FDFACT1/ FDFACT2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1372
    Target NamePILRB
    Gene ID29990,114669761
    Gene Symbol and SynonymsFDFACT1,FDFACT2,PILRB
    Uniprot AccessionQ9UKJ0
    Uniprot Entry NamePILRB_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000121716
    Target ClassificationN/A

    The target: PILRB, gene name: PILRB, also named as FDFACT1, FDFACT2. The paired immunoglobin-like type 2 receptors consist of highly related activating and inhibitory receptors that are involved in the regulation of many aspects of the immune system. The paired immunoglobulin-like receptor genes are located in a tandem head-to-tail orientation on chromosome 7. This gene encodes the activating member of the receptor pair and contains a truncated cytoplasmic tail relative to its inhibitory counterpart (PILRA), that has a long cytoplasmic tail with immunoreceptor tyrosine-based inhibitory (ITIM) motifs. This gene is thought to have arisen from a duplication of the inhibitory PILRA gene and evolved to acquire its activating function. [provided by RefSeq, Jun 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.